Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Dow
Baxter
McKesson
Mallinckrodt
Boehringer Ingelheim
Express Scripts

Last Updated: October 17, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Brincidofovir

See Plans and Pricing

« Back to Dashboard

Drug Development Status for Brincidofovir: Sponsors, patents, clinical trial progress

Brincidofovir is an investigational drug.

There have been 10 clinical trials for Brincidofovir. The most recent clinical trial was a Phase 3 trial, which was initiated on August 1st 2013.

The most common disease conditions in clinical trials are Adenoviridae Infections, Virus Diseases, and Hemorrhagic Fever, Ebola. The leading clinical trial sponsors are Chimerix and [disabled in preview].

There are seven US patents protecting this investigational drug and seventy-eight international patents.

Recent Clinical Trials for Brincidofovir
TitleSponsorPhase
Open Label Study of IV Brincidofovir in Adult Transplant Recipients With Adenovirus ViremiaChimerixPhase 2
The AdAPT Trial; Adenovirus After Allogeneic Pediatric TransplantationChimerixPhase 2
SURPASS: A Randomized, Double-Blind, Multicenter Study of the Efficacy, Safety, and Tolerability of Brincidofovir Versus Valganciclovir for the Prevention of Cytomegalovirus (CMV) Disease in CMV Seropositive Kidney Transplant Recipients (BCV CMV vGCVChimerixPhase 3

See all Brincidofovir clinical trials

Clinical Trial Summary for Brincidofovir

Top disease conditions for Brincidofovir
Top clinical trial sponsors for Brincidofovir

See all Brincidofovir clinical trials

US Patents for Brincidofovir

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Brincidofovir   Start Trial Phosphonate ester derivatives and methods of synthesis thereof Chimerix, Inc. (Durham, NC)   Start Trial
Brincidofovir   Start Trial Compounds, compositions and methods for treating ocular conditions Chimerix, Inc. (Durham, NC)   Start Trial
Brincidofovir   Start Trial Morphic forms of hexadecyloxypropyl-phosphonate esters and methods of synthesis thereof Chimerix, Inc. (Durham, NC)   Start Trial
Brincidofovir   Start Trial Phosphonate ester derivatives and methods of synthesis thereof Chimerix Inc. (Durham, NC)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Brincidofovir

Drugname Country Document Number Estimated Expiration Related US Patent
Brincidofovir Australia 2011295937 2030-08-31   Start Trial
Brincidofovir Brazil 112013004925 2030-08-31   Start Trial
Brincidofovir Canada 2809679 2030-08-31   Start Trial
Brincidofovir China 103209985 2030-08-31   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Express Scripts
Johnson and Johnson
AstraZeneca
Dow
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.